 DUBLIN and SOUTH SAN FRANCISCO, Calif., Sept. 15, 2021 PRNewswire -- Theravance Biopharma, Inc. Theravance Biopharma or the Company NASDAQ: TBPH today announced strategic actions to focus on leveraging its expertise in developing and commercializing respiratory therapeutics in order to maximize shareholder value. 